SPECIAL NOTICE
A -- Tissue procurement for Humanized Mice - NOI1201156
- Notice Date
- 6/13/2018
- Notice Type
- Special Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Rockville, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001, United States
- ZIP Code
- 20857-0001
- Solicitation Number
- NOI-1201156
- Point of Contact
- Telisha Wilson, Phone: 2404027572
- E-Mail Address
-
telisha.wilson@fda.hhs.gov
(telisha.wilson@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Tissue procurement for Humanized Mice PRESOLICITATION NOTICE: INTENT TO AWARD A SOLE-SOURCE CONTRACT INTENDED SOURCE: Advanced Bioscience Resources, Inc. ANTICIPATED PERIOD of PERFORMANCE: 07/15/2018-07/14/2019 DESCRIPTION OF REQUIREMENT: Pursuant to the authority of 41 USC 3304(a)(1), as implemented by Federal Acquisition Regulation (FAR) Subpart 13.501(a)(1)(ii), the U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grant Services (OAGS) intends to award a sole source contract to Advanced Bioscience Resources, Inc., ABR is the only company in the U. S. capable of supplying tissues suitable for HM research. No other company or organization is capable of fulfilling the need. The Government intends to solicit and negotiate directly with Advanced Bioscience Resources (ABR) Inc. and no solicitation will be issued. The objective is to acquire Tissue for Humanized Mice. ABR is the only company that can provide the human fetal tissue needed to continue the ongoing research being led by the FDA. Fresh human tissues are required for implantation into severely immune-compromised mice to create chimeric animals that have a human immune system. This human immune system allows us to test biological drug products for safety and efficacy. This is necessary because these drug products do not bind non-human species drug targets. The applicable North American Industry Classification System (NAICS) code for this acquisition 541711, Research and Development in Biotechnology. This notice of intent is not a request for competitive proposals or quotations; however, if any interested party believes they can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities shall be submitted in writing and shall contain material in sufficient detail to allow the government to determine if the party can perform the requirement. A determination by the Government not to compete this proposed requirement based on responses to this notice is solely within the discretion of the Government. All interested parties shall express their interest and capabilities in writing via email to Telisha.Wilson@fda.hhs.gov within fifteen (15) days after the date of publication of this notice. No faxed documents will be accepted. If no responsive statements are received within fifteen (15) days, an award will subsequently be made to American College of Medical Toxicology, Inc. This is a Federal contract opportunity; FDA-NOI-1201156 for services at Food and Drug Administration Office of Acquisitions and Grants Services - Rockville, MD. Response Due NLT 10:00 AM 06/28/ 2018 Solicitation Number FDA-NOI-1201156 Set-Aside No Set-Aside Used Contact(s) Telisha Wilson Agency Department of Health and Human Services Office Food and Drug Administration Location Office of Acquisitions and Grants Services - Rockville
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/NOI-1201156/listing.html)
- Record
- SN04954076-W 20180615/180613231209-b9302b7a3c1cd922048de3531dd5b889 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |